bluebird bio, Inc. (BLUE)
NASDAQ: BLUE · IEX Real-Time Price · USD
0.923
-0.052 (-5.35%)
At close: Jul 2, 2024, 4:00 PM
0.933
+0.010 (1.06%)
After-hours: Jul 2, 2024, 7:47 PM EDT
bluebird bio Market Cap
bluebird bio has a market cap or net worth of $177.92 million as of July 2, 2024. Its market cap has decreased by -50.54% in one year.
Market Cap
177.92M
Enterprise Value
307.33M
1-Year Change
-50.54%
Ranking
Category
Stock Price
$0.92
Market Cap Chart
Since June 19, 2013, bluebird bio's market cap has decreased from $588.50M to $177.92M, a decrease of -69.77%. That is a compound annual growth rate of -10.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 106.60M | -29.36% |
| Dec 29, 2023 | 150.90M | -73.70% |
| Dec 30, 2022 | 573.70M | -18.09% |
| Dec 31, 2021 | 700.40M | -75.61% |
| Dec 31, 2020 | 2.87B | -40.85% |
| Dec 31, 2019 | 4.86B | -10.51% |
| Dec 31, 2018 | 5.43B | -33.53% |
| Dec 29, 2017 | 8.16B | 254.64% |
| Dec 30, 2016 | 2.30B | -2.28% |
| Dec 31, 2015 | 2.36B | -10.90% |
| Dec 31, 2014 | 2.64B | 429.89% |
| Dec 31, 2013 | 498.90M | -15.23% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pyxis Oncology | 194.92M |
| 23andMe Holding Co. | 191.79M |
| Inogen | 191.68M |
| Rani Therapeutics Holdings | 191.60M |
| Cybin | 190.59M |
| Design Therapeutics | 189.26M |
| Lineage Cell Therapeutics | 188.31M |
| Generation Bio Co. | 187.61M |